Palonosetron

CHEMBL1189679 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
296.4 g/mol
LogP
2.8
Phase
4

This medication is used to prevent nausea and vomiting that often occurs with chemotherapy or surgery.

Berat Molekul

296,4000 g/mol

LogP

2,80

TPSA

23,60 Ų

Lipinski RO5

Lulus

Area Terapeutik

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C1c2cccc3c2[C@H](CCC3)CN1[C@@H]1CN2CCC1CC2

InChI

InChI=1S/C19H24N2O/c22-19-16-6-2-4-14-3-1-5-15(18(14)16)11-21(19)17-12-20-9-7-13(17)8-10-20/h2,4,6,13,15,17H,1,3,5,7-12H2/t15-,17-/m1/s1

Molecular Formula

C19H24N2O

HBD / HBA

- / 2

Ikatan yang Dapat Dirotasi

1

Atom Berat

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

This medication is used to prevent nausea and vomiting that often occurs with chemotherapy or surgery.

Yes, Palonosetron is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1189679. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6337614. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.